Despite its success in rushing COVID-19 vaccines to market, the biopharmaceutical supply chain is far from perfect.
The consumer products giant Unilever plc is promising a “living wage” for all of its supply-chain workers by the year 2030. Can it make good on that pledge?
At a time when warehouses are under intense pressure to process and ship product to demanding customers, how can we keep warehouse workers safe?
Timely, incisive articles delivered directly to your inbox.